SCHEMBL28343283

SCHEMBL28343283

O=C(OC(=O)c1ccc(Cl)cc1)OC(=O)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
ALOX15 P16050 2/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
GSK3B P49841 2/20 0.46
SRD5A2 P31213 1/20 0.46
MAPK1 P28482 1/20 0.46
HPGD P15428 1/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20184126 0.91 CES2 (0.50) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL28775846 0.90 CES2 (0.59) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL247590 0.90 CES2 (0.59) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL18050293 0.84 CES2 (0.52) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL18050295 0.84 CES2 (0.52) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL28343284 0.84 ALOX15 (0.56) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL11419878 0.82 SMN1; SMN2 (0.53) CES2CES1TSHRSMN1; SMN2CA1
SCHEMBL247591 0.82 CES2 (0.65) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL9994271 0.82 RAB9A (0.58) CES2CES1ALOX15TSHRSMN1; SMN2
SCHEMBL6444130 0.82 ALDH1A1 (0.52) CES2CES1ALOX15TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110621678-A Antitumor compounds 法马马有限公司 2019-12-27 CN disclosed